Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma.

Trachoma is caused by Chlamydia trachomatis (Ct). It is the leading infectious cause of blindness worldwide and the target of global elimination efforts1,2. Trachoma is treated with surgery for those with trachomatous trichiasis (TT), mass drug administration (MDA) of antibiotics, promotion of facial cleanliness and environmental improvement, collectively termed the SAFE strategy. The aim of the A, F and E components of the SAFE strategy is to reduce prevalence and transmission of ocular Ct infection.

Source: Journal of Infection - January 31, 2020 Category: Infectious Diseases Authors: Robert Butcher, Becca Handley, Mackline Garae, Raebwebwe Taoaba, Harry Pickering, Annie Bong, Oliver Sokana, Matthew J Burton, Nuno Sep úlveda, Ana Cama, Richard Le Mesurier, Anthony W. Solomon, David Mabey, Fasihah Taleo, Rabebe Tekeraoi, Chrissy h Robe Source Type: research